UnknownNot Applicable

The Correlation Between Cirrhotic Cardiomyopathy and Perioperative Cardiovascular Events in Liver Transplantation

850 participantsStarted 2021-08-01

Plain-language summary

Liver transplantation is an effective treatment for end-stage liver disease. Cardiovascular complications are the common causes of death in liver transplant recipients. The presence of cirrhosis cardiomyopathy has a potential impact on the prognosis of liver transplant recipients. Therefore, it is important to identify the high risk factors with cirrhotic cardiomyopathy before transplantation, so as to intervene earlier and improve the prognosis of patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnostic criteria for decompensated liver cirrhosis: according to the guidelines for diagnosis and treatment of liver cirrhosis in 2019;
✓. Diagnostic criteria for cirrhotic cardiomyopathy: in accordance with the revised criteria of CCM of international multidisciplinary Alliance for cirrhotic cardiomyopathy in 2019, the preoperative echocardiographic images of all patients were reviewed, and the systolic and diastolic dysfunction of all patients were evaluated.

Exclusion criteria

✕. the compensatory liver cirrhosis, primary liver cancer without liver cirrhosis
✕. Multiple organ transplantation or multiple organ transplantation
✕. The preoperative echocardiographic data were not fully recorded, so that the exact diagnosis could not be made
✕. There was no follow-up data or baseline data

What they're measuring

perioperative cardiovascular events

Timeframe: 2012.1.1-2022.8

Trial details

NCT IDNCT04976764

SponsorThe Affiliated Hospital of Qingdao University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-08-01

Contact for this trial

shenghua Bi

+8618863608195 bsh112359@163.com

View on ClinicalTrials.gov More Cirrhosis, Liver trials